Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization.
about
Natural history of upper extremity musculoskeletal symptoms and resulting work limitations over 3 years in a newly hired working populationAn economic model of long-term use of celecoxib in patients with osteoarthritisThe cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgeryDissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the diseaseBody-mass index and symptoms of gastroesophageal reflux in women.Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait.Specific count model for investing the related factors of cost of GERD and functional dyspepsia.The societal gain of medical development and innovation in gastroenterology.Rate and yield of repeat upper endoscopy in patients with dyspepsia.Classification of adults suffering from typical gastroesophageal reflux disease symptoms: contribution of latent class analysis in a European observational studyHealth-related quality of life and gastrointestinal disease.Patient-centred endpoints in economic evaluations of gastro-oesophageal reflux disease.Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort studySystematic review: the impact of gastro-oesophageal reflux disease on work productivity.Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins.The association between reflux esophagitis and psychosocial stressOn-demand therapy for gastroesophageal reflux disease.Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapyEvidence-based assessment of the efficacy of esomeprazole for the healing of erosive esophagitis.Acid peptic diseases: pharmacological approach to treatment.Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.Validation of a symptom diary for patients with gastro-oesophageal reflux disease.Long-term management of gastroesophageal reflux disease with pantoprazole.Treatment of gastroesophageal reflux disease: to step or not to step.Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study.Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan.Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and Sweden.The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy.Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study
P2860
Q23910411-A9EBB990-73EB-4842-BC5F-D3C5CB44AE61Q28218005-4B668B14-08C7-4CCC-B1DD-706DD21EB51AQ28353957-4A6C2535-B243-4C13-AAEB-9BFD6A3960D3Q28580941-18028E1F-BA58-43A0-B5E2-18936E6D2484Q33245320-C17FD723-D956-43FB-81CF-ED43E0C7BDBEQ33529303-CB7D08D8-4ECF-447A-B3A8-AEB7D39DC361Q33596702-DD32FB5D-BD68-4D8C-AE70-17D91C572559Q33695447-250C0B8C-8D85-4CEE-AA11-E35273647F67Q33879449-28E05FB7-D46E-4313-B9BC-B2B1FD6DE453Q33890066-A616CA74-973F-4B9C-9662-B318B836A3F8Q34631350-C4801F88-CB35-4B11-A4A4-144A49E9D3DFQ34786709-40652EEB-E4F4-4CB6-8F04-84D4A5AEA13BQ35091373-2DA6F68C-45DD-42AD-AE1E-BF37FB185141Q36496809-FAC1B670-A3FC-4FA2-A6DE-E2AAF92F8453Q36536726-292C320D-62CE-4D26-834B-E51A113C9BCAQ36609205-84AB4F18-F5A3-4E1D-83F6-82DBD10F34E2Q36622014-5263EF7F-67DE-4992-889F-704E9D6322D9Q36677627-A7FE0A93-6179-482B-9C15-70903282FE7FQ36803119-A39BA532-FBB1-4082-ACCC-D369AAF001D9Q37609174-ED2AEC9B-C71D-453B-9D57-EA16CFB946B2Q37913063-6FBDC763-830A-408D-8CA7-C828265CD4F1Q39389320-B669DCEA-439D-47E6-B9E7-EE292242A883Q40355201-CBDE3270-0670-4926-84F5-0C8D3A98377AQ42429093-7E7CA1E2-8B16-4E0D-A6D5-2931664446E2Q43648678-99C54BC5-520A-48FD-8A33-2BD153F5D691Q43742978-71CC23D8-B015-4380-99FC-58357DB7C8A6Q48531759-25D13189-F56E-48B0-99F2-E7CB292805E0Q50740139-01D46B8A-1644-4847-A96F-73FB42D1D234Q53359666-1F460286-32E8-49BF-8765-6CB5FAC34BC9Q57819642-6D8E5B57-2E54-40FD-B400-38141C996E83
P2860
Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Work loss costs due to peptic ...... alth maintenance organization.
@ast
Work loss costs due to peptic ...... alth maintenance organization.
@en
type
label
Work loss costs due to peptic ...... alth maintenance organization.
@ast
Work loss costs due to peptic ...... alth maintenance organization.
@en
prefLabel
Work loss costs due to peptic ...... alth maintenance organization.
@ast
Work loss costs due to peptic ...... alth maintenance organization.
@en
P2093
P2860
P1476
Work loss costs due to peptic ...... alth maintenance organization.
@en
P2093
P2860
P304
P356
10.1111/J.1572-0241.2000.01861.X
P407
P577
2000-03-01T00:00:00Z